GTH 4.02 (+0%)
US37186H1005Medical Diagnostics & ResearchDiagnostics & Research

Genetron Holdings (GTH) Competitor Comparison

We are evaluating the key criteria listed to compare Genetron Holdings (GTH) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - GTH ranking 0 / 58

These are the competitors of Genetron Holdings in the industry Diagnostics & Research ranked by linearity 3 years
1. Waters WAT
97.37
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. Quest Diagnostics DGX
21.12
4. PerkinElmer PKI
16.14
5. Anixa Biosciences ANIX
15.75
6. Laboratory Corp of America Holdings LH
14.91
7. Agilent Technologies A
12.52
8. Qiagen QGEN
10.73
9. Syneos Health SYNH
10.68
10. Sera Prognostics SERA
10.67
11. Thermo Fisher Scientific TMO
9.77
12. Danaher DHR
9.56
13. Mettler-Toledo MTD
7.73
14. Heska HSKA
7.67
15. Exact Sciences EXAS
7.55
16. Olink Holding OLK
6.67
17. IQVIA Holdings IQV
6.27
18. Icon ICLR
6.02
19. IDEXX Laboratories IDXX
5.05
20. Bioventus BVS
4.99
21. Global Cord Blood CO
4.22
22. Myriad Genetics MYGN
4.09
23. National Research NRC
4.02
24. Sotera Health SHC
4.02
25. Medpace Holdings MEDP
3.52
26. Charles River Laboratories CRL
3.47
27. Twist Bioscience TWST
2.92
28. Psychemedics PMD
2.79
29. Illumina ILMN
2.58
30. Enzo Biochem ENZ
2.57
31. NeoGenomics NEO
2.51
32. MaxCyte MXCT
2.49
33. CareDx CDNA
2.48
34. MDxHealth MDXH
2.42
35. Exagen XGN
2.23
36. Neogen NEOG
2.23
37. Biodesix BDSX
2.19
38. Guardant Health GH
2.13
39. Interpace Biosciences IDXG
2.01
40. Trinity Biotech TRIB
2
41. Neuronetics STIM
1.98
42. Fulgent Genetics FLGT
1.88
43. Precipio PRPO
1.86
44. Personalis PSNL
1.83
45. DarioHealth DRIO
1.79
46. Organovo Holdings ONVO
1.79
47. Pacific Biosciences of California PACB
1.75
48. Co-Diagnostics CODX
1.7
49. Prenetics Global PRE
1.59
50. bioAffinity Technologies BIAF
1.55
51. SeqLL SQL
1.48
52. Inotiv NOTV
1.46
53. DexCom DXCM
1.45
54. Lantheus Holdings LNTH
1.41
55. Aspira Womens Health AWH
1.38
56. Natera NTRA
1.03
57. Meridian Bioscience VIVO
0.73
58. RadNet RDNT
0.69

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.